Impact of Heparin-Induced Thrombocytopenia on Postoperative Outcomes After Cardiac Surgery

Annals of Thoracic Surgery

Volumn 84, Issue 5, 2007, Pages 1548-1555

  Kerendi, Faraz ^a   Thourani, Vinod H ^a   Puskas, John D ^a   Kilgo, Patrick D ^b   Osgood, Michael ^a   Guyton, Robert A ^a   Lattouf, Omar M ^a  

^a Clinical Research Center   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART SURGERY; HEART VALVE SURGERY; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SEPSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL RISK; THROMBOCYTE COUNT; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; FEMALE; HEPARIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET FACTOR 4; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; ROC CURVE; THROMBOCYTOPENIA; THROMBOSIS;

EID: 35348966904     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.05.080     Document Type: Article

References (17)

1. Martel N., Lee J., and Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 106 (2005) 2710-2715
2. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 Suppl (2004) 311-337
3. Warkentin T.E. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban. Thromb Res 110 (2003) 73-82
4. Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121 (2003) 535
5. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131
6. Warkentin T.E., and Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344 (2001) 1286-1292
7. Pappalardo F., Crescenzi G., Franco A., and Zangrillo A. Early heparin-induced thrombocytopaenia (HIT) after cardiac surgery. Eur J Anaesthesiol 23 (2006) 806-808
8. Bauer T.L., Arepally G., Konkle B.A., et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95 (1997) 1242-1246
9. Portney L.P., and Watkins M.P. Foundations of clinical research. Applications to practice. 2nd ed. (2000), Prentice Hall, Upper Saddle River, NJ 99-107
10. Arepally G.M., and Ortel T.L. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med 355 (2006) 809-817
11. Greinacher A., Farner B., Kroll H., et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94 (2005) 132-135
12. Arepally G.M., and Mayer I.M. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood 98 (2001) 1252-1254
13. Khairy M., Lasne D., Brohard-Bohn B., et al. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates. Thromb Haemost 85 (2001) 1090-1096
14. Khairy M., Lasne D., Amelot A., et al. Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood. Thromb Haemost 92 (2004) 1411-1419
15. Walenga J.M., Jeske W.P., Prechel M.M., and Bakhos M. Newer insights on the mechanism of heparin-induced thrombocytopenia. Semin Thromb Hemost 30 Suppl 1 (2004) 57-67
16. Warkentin T.E., and Sheppard J.A. Testing for heparin-induced thrombocytopenia antibodies. Transfus Med Rev 20 (2006) 259-272
17. Zwicker J.I., Uhl L., Huang W.Y., et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost 2 (2004) 2133-2137